{{medical}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 459977512
| IUPAC_name = (8''S'',9''R'',10''S'',11''S'',13''S'',14''S'',16''S'',17''R'')-9-Fluoro- 11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro- 3''H''-cyclopenta[''a'']phenanthren-3-one
| image = Betamethasone.svg
| image2 = Betamethasone2.png
<!--Clinical data-->
| tradename = Celestone
| Drugs.com = {{drugs.com|monograph|betamethasone}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status = Rx-only
| routes_of_administration = Oral, Topical, IM
<!--Pharmacokinetic data-->
| bioavailability = ?
| metabolism = [[肝臟|肝臟]]：[[CYP3A4|CYP3A4]]
| elimination_half-life = 36-54 小時
| excretion = [[腎臟|腎臟]]（尿液排除）
<!--Identifiers-->
| IUPHAR_ligand = 7061
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 378-44-9
| ATC_prefix = A07
| ATC_suffix = EA04
| ATC_supplemental = {{ATC|C05|AA05}} {{ATC|D07|AC01}} {{ATC|H02|AB01}} {{ATC|R01|AD06}} {{ATC|R03|BA04}} {{ATC|S01|BA06}} {{ATC|S02|BA07}} {{ATC|S03|BA03}}
| PubChem = 9782
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00443
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 9399
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9842X06Q6M
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00244
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3077
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 632
<!--Chemical data-->
| C=22 | H=29
| F=1 | O=5
| molecular_weight = 392.461
| smiles = O=C(CO)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)CC[C@H]4[C@@H]2C[C@@H]3C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UREBDLICKHMUKA-DVTGEIKXSA-N
}}
<!-- Definition and medical uses -->
'''倍他米松'''（{{lang|en|Betamethasone}}）為一[[皮質類固醇|固醇類藥物]]<ref name=AHFS2015>{{cite web|title=Betamethasone|url=http://www.drugs.com/monograph/betamethasone.html|publisher=The American Society of Health-System Pharmacists|accessdate=Dec 2, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20151208152909/http://www.drugs.com/monograph/betamethasone.html|archivedate=2015-12-08|df=}}</ref>，可用於治療多種[[风湿|風濕免疫性疾病]]，如[[類風濕性關節炎|類風濕性關節炎]]、[[全身性紅斑狼瘡|全身性紅斑狼瘡]]，以及[[皮膚炎|皮膚炎]]和[[銀屑病|銀屑病]]等等免疫性皮膚疾病。其他適應症還包含[[哮喘|哮喘]]及{{tsl|en|angioedema|血管水腫}}等過敏性疾病，也可在[[早產|早產]]時給予協助胎兒肺部發育。本品亦可治療[[克隆氏症|克隆氏症]]、[[白血病|白血病]]，也可與{{tsl|en|fludrocortisone|氟氫可的松}}合用治療{{tsl|en|adrenocortical insufficiency|腎上腺皮質機能不足}}<ref name=AHFS2015/>。本品可透過口服、[[肌肉注射|肌肉注射]]，或以外用藥膏給藥<ref name=AHFS2015/><ref name=AHFS2015Top>{{cite web|title=Betamethasone topical|url=http://www.drugs.com/monograph/betamethasone-topical.html|publisher=The American Society of Health-System Pharmacists|accessdate=Dec 2, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20151208025858/http://www.drugs.com/monograph/betamethasone-topical.html|archivedate=2015-12-08|df=}}</ref>。若透過注射給藥，其[[抗炎性|抗發炎]]效果約會於給藥後2小時候開始發揮作用，藥效可維持長達七天<ref name=AHFS2015/>。

<!-- Side effects and mechanism -->
嚴重副作用包含增加感染風險、肌肉無力、[[全身型過敏性反應|全身型過敏性反應]]，以及[[思覺失調|思覺失調]]<ref name=AHFS2015/>。長期使用則可能導致腎上腺機能不足<ref name=AHFS2015/>。長期用藥者驟然停藥相當危險<ref name=AHFS2015/>。常用含有倍他米松成分軟膏者，可能導致[[先天性遗传多毛症|多毛症]]及皮膚敏感<ref name=AHFS2015Top/>。本品屬於[[糖皮质激素|糖皮质激素]]類藥物<ref name=AHFS2015/>。

<!-- Society and culture -->
本品自1961年開始用於醫療<ref name=AHFS2015/>，其軟膏劑型列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref>。本品屬於[[通用名药物|通用名药物]]<ref name=AHFS2015/>，在美國口服藥丸及注射劑要價不斐，軟膏劑型價格則較為低廉<ref name=Ric2015>{{cite book |last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=186,201}}</ref>。

==參見==
*{{tsl|en|Betamethasone/dexchlorpheniramine||Betamethasone/dexchlorpheniramine}}

==參考文獻==
{{Reflist}}

==外部連結==
*{{cite web |title=Betamethasone |url=http://www.safefetus.com/DrugDetail.asp?DrugId=709&TradeName=Betaval&TradeId=775 |publisher=safefetus.com |deadurl=yes |archiveurl=https://web.archive.org/web/20060214045414/http://safefetus.com/DrugDetail.asp?DrugId=709&TradeName=Betaval&TradeId=775 |archivedate=2006-02-14 |df= }}

{{Glucocorticoids}}
{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}
{{Vasoprotectives}}
{{Nasal preparations}}
{{Drugs for obstructive airway diseases}}
{{Otologicals}}
{{Glucocorticoidics}}

[[Category:皮质类固醇|Category:皮质类固醇]]
[[Category:有机氟化合物|Category:有机氟化合物]]
[[Category:耳科用药|Category:耳科用药]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]